aca24@aca-pharma.de/ +49 341 223 292 36

Online Seminar “Environmental risk assessment of medicinal products for human use” according to revised EMA guideline (EMEA/CHMP/SWP/4447/00 Rev. 1) coming in force in September 2024

Module 1: 18.09.2024, 08:30 a.m. – 11:45 a.m.
Module 2: 19.09.2024, 08:30 a.m. – 11:45 a.m.

Seminar language: German

Numerous changes and extended requirements result from the revision of the guideline, e.g., with regard to data requirements, test strategies (especially for antibiotics), the assessment of possible risks due to bioaccumulation in the environment and the methodology to be used.

The increasing importance of environmental considerations is also evident in the draft of the revised Medicinal Products Directive 2001/83/EC, which takes into account the objectives of the European ‘Green Deal’ for greater environmental protection and sustainability. A ‘lifecycle’ assessment of medicinal products is also required from an environmental point of view.

This online seminar is divided into two modules (which can be booked individually and together) and is practice-orientated. The focus is on the preparation of ERAs based on the revised guideline with its many new features.

Module 1: Legal framework, data analysis and introduction to environmental risk assessment

Zeit (CE(S)T) Thema
08:30 – 10:00 Introduction and overview of the revised Directive 2001/83/EC with reference to the environment
Principles and overview of the revised ERA Guideline EMEA/CHMP/SWP/4447/00 Rev. 1
10:00 – 10:15 Break
10:15 – 11:45 Data analysis
ERA Assessment Phase-I
PBT screening and assessment

Module 2: Phase-II strategy and extended environmental risk assessment

Zeit (CE(S)T) Thema
08:30 – 10:00 Compartment-specific Phase II assessment, Part 1: Physico-chemical properties, fate in the environment, ecotoxicity, exposure action values
10:00 – 10:15 Pause
10:15 – 11:45 Compartment-specific Phase II assessment, Part 2: Surface water, sediment, wastewater, soil, groundwater
ERA-Template Module 1.6.1
Summary; Q&A

 In cooperation with

 

Comments are closed.